Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-16,900
Closed -$4.68M 741
2022
Q4
$4.68M Sell
16,900
-6,700
-28% -$1.89M 0.26% 83
2022
Q3
$6.3M Buy
+23,600
New +$5.01M 0.3% 74
2022
Q2
Sell
-10,500
Closed -$2.21M 1111
2022
Q1
$2.21M Sell
10,500
-36,900
-78% -$8.02M 0.08% 249
2021
Q4
$11.4M Buy
47,400
+34,100
+256% +$8.77M 0.4% 50
2021
Q3
$3.76M Sell
13,300
-11,700
-47% -$3.83M 0.16% 120
2021
Q2
$8.66M Sell
25,000
-79,500
-76% -$24.1M 0.36% 56
2021
Q1
$29.2M Sell
104,500
-100,500
-49% -$27.1M 1.2% 13
2020
Q4
$50.2M Buy
205,000
+157,300
+330% +$40.6M 1.92% 7
2020
Q3
$13.5M Buy
47,700
+46,900
+5,863% +$13.1M 0.64% 23
2020
Q2
$215K Sell
800
-2,000
-71% -$601K 0.01% 484
2020
Q1
$886K Sell
2,800
-2,200
-44% -$668K 0.07% 222
2019
Q4
$1.48M Buy
+5,000
New +$1.39M 0.08% 197

Other funds holding BIIB

CSS LLC's BIIB Position: Q1 2026 in Review

CSS LLC reduced its Biogen (BIIB) stake by 55% in Q1 2026, selling an estimated $619K and leaving 2,720 shares worth $499K. The position accounts for 0.02% of the portfolio, ranked #525.

CSS LLC first reported a position in BIIB in Q1 2020 and has held it in 12 quarters since. The position peaked at $5.14M in Q2 2020. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • CSS LLC held 2,720 shares of Biogen worth $499K as of Q1 2026.
  • CSS LLC sold 3,360 Biogen shares in Q1 2026, an estimated $619K.
  • Biogen made up 0.02% of CSS LLC's portfolio in Q1 2026, its #525 holding.
  • CSS LLC first reported a position in Biogen in Q1 2020 and has held it in 12 quarters since.
  • CSS LLC's Biogen position peaked at $5.14M in Q2 2020.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.